Table 2

Regression and progression of premalignant gastric lesions in terms of most severe lesion

Follow-up
NormalGastritisAGIMLGDHGDInvasive neoplasiaRegressionStableProgression
n=279403613183422103 (37%)165 (59%)11 (4%)
Baseline
 Normal
 Gastritis
 AG1131250004 (36%)2 (18%)5 (45%)
 IM24436311016222177 (32%)162 (66%)5 (2%)
 LGD231411610022 (96%)1 (4%)0 (0%)
 HGD*100000010 (0%)0 (0%)1 (100%)
  • Gray colour denote the patients who had the same histology at both baseline and during follow-up (mean follow-up 57 months). Above the diagonal indicates patients in whom histology showed progression to a more severe lesion. Under the diagonal indicates patients in whom histology showed regression to a less severe lesion.

  • *This patient with HGD at baseline was down staged to severe IM at first surveillance endoscopy. At second surveillance endoscopy, an early gastric cancer was found.

  • AG, atrophic gastritis; HGD, high-grade adenoma/dysplasia.; IM, intestinal metaplasia; LGD, low-grade adenoma/dysplasia.